Glycostem sponsored research will be presented by Professor Michael Heuser from Hannover Medical School the during ASCO 2021. The e-poster presentation will be made available as of Friday 4^th June, 2021 (09:00 EDT/15:00 CEST).
 

Glycostem to participate in an virtual event hosted by the Netherlands Enterprise Agency (Rijksdienst voor Ondernemend Nederland, RVO): Scale-up mission Biotech - Boston and New York, during 21^st May to 24^th June, 2021.

Glycostem will present on the virtual Advanced Therapies Congress & Expo 2021 during 19^th to 21^st May, 2021. Advanced Therapies Congress & Expo is the world’s largest commercially focused ATMP event and this is the virtual event. An in-person event will be held on 5^th and 6^th October 2021 in London. 

Glycostem to present virtually on the 3^rdAllogeneic Cell Therapies Summit on 19^th May 2021, to share our experiences on comparability testing for US required raw material sourcing vs. European sourcing. 

Glycostem will present on the virtual Berenberg Conference USA 2021 on 18^th May, 2021, to share the latest updates of our company and products, and host one-on-one meetings with investors.

Glycostem to present at the 18th CIMT Annual Meeting virtually with etalk presentation: Ex vivo expanded NK cells show potent anti-tumour activity against melanoma.